Emmanuel André
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- Tuberculosis Research and Epidemiology 30
- SARS-CoV-2 and COVID-19 Research 24
- SARS-CoV-2 detection and testing 18
- COVID-19 Clinical Research Studies 8
- Epidemiology 43
- Mycobacterium research and diagnosis 22
- Pneumonia and Respiratory Infections 8
- Co-authors
- Pieter Vermeersch (10 shared papers)Katrien Lagrou (10 shared papers)Marc Van Ranst (12 shared papers)Jan Van Elslande (9 shared papers)Piet Maes (15 shared papers)Joren Raymenants (11 shared papers)Johan Neyts (2 shared papers)Els Houben (4 shared papers)
- Journals
- Scientific Reports (6 papers)Clinical Microbiology and Infection (6 papers)PLoS ONE (4 papers)Nature Communications (3 papers)International Journal of Infectious Diseases (3 papers)
- Partner nations
- BelgiumFranceDemocratic Republic of the Congo
In The Last Decade
Emmanuel André
85 papers receiving 2.3k citations
Emmanuel André's Hit Papers
Peers
Comparison fields: 5 of 155
- Infectious Diseases 1.8k
- Modeling and Simulation 193
- Epidemiology 712
- Neurology 146
- Molecular Medicine 47
Countries citing papers authored by Emmanuel André
This map shows the geographic impact of Emmanuel André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel André more than expected).
Fields of papers citing papers by Emmanuel André
This network shows the impact of papers produced by Emmanuel André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel André. The network helps show where Emmanuel André may publish in the future.
Co-authors
The 25 scholars most cited alongside Emmanuel André, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern Hit paper breakdown → | 2022 | 290 |
| 2 | 2020 | 186 | |
| 3 | 2020 | 147 | |
| 4 | 2014 | 132 | |
| 5 | 2020 | 107 | |
| 6 | 2005 | 101 | |
| 7 | 2018 | 96 | |
| 8 | 2021 | 92 | |
| 9 | Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain. | 2020 | 85 |
| 10 | 2016 | 67 | |
| 11 | 2022 | 65 | |
| 12 | 2020 | 63 | |
| 13 | 2022 | 54 | |
| 14 | 2020 | 51 | |
| 15 | 2017 | 46 | |
| 16 | 2016 | 36 | |
| 17 | 2019 | 35 | |
| 18 | 1996 | 35 | |
| 19 | 2023 | 34 | |
| 20 | 2019 | 33 |
About Emmanuel André
Emmanuel André is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Modeling and Simulation and Surgery, having authored 89 papers that have together received 2.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (30 papers), SARS-CoV-2 and COVID-19 Research (24 papers), Mycobacterium research and diagnosis (22 papers), SARS-CoV-2 detection and testing (18 papers), COVID-19 epidemiological studies (12 papers), Pneumonia and Respiratory Infections (8 papers), COVID-19 Clinical Research Studies (8 papers) and Infectious Diseases and Mycology (7 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Modeling and Simulation (193 citations), Epidemiology (712 citations), Neurology (146 citations) and Molecular Medicine (47 citations). Emmanuel André has collaborated with scholars based in Belgium, France and Democratic Republic of the Congo. Frequent co-authors include Pieter Vermeersch, Katrien Lagrou, Marc Van Ranst, Jan Van Elslande, Piet Maes, Joren Raymenants, Johan Neyts, Els Houben, Stefanie Desmet and Melissa Depypere. Their work appears in journals such as Scientific Reports, Clinical Microbiology and Infection, PLoS ONE, Nature Communications and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.